Ariti S.A of Athens, Greece, announced today a strategic partnership with Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases. Through this collaboration, Ariti will spearhead multiple initiatives aiming to raise awareness of rare melanocortin-4 receptor (MC4R) pathway…
Ariti S.A and Insmed Ireland Limited recently signed an agreement for the Greek territory, aiming at increasing awareness of non-tuberculosis mycobacteria pulmonary disease. This agreement marks an important milestone for the pharmaceutical business unit of Ariti as it not only reinforces the current portfolio of its activities but enhances its…
Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system. 2,300,000 people worldwide are sick of it. A short documentary film for those who appreciate life.sMS – Sharing Multiple Sclerosis